Biochemical Pharmacology
Andrographolide suppresses the malignancy of triple-negative breast cancer by reducing THOC1-promoted cancer stem cell characteristics
Publication date: Available online 27 October 2022Source: Biochemical PharmacologyAuthor(s): Yi-Ju Chou, Ching-Cheng Lin, Ya-Chi Hsu, Jia-Ling Syu, Ling-Ming Tseng, Jen-Hwey Chiu, Jeng-Fan Lo, Chao-Hsiung Lin, Shu-Ling Fu